Skip to main navigation Skip to search Skip to main content

Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer

  • Lorraine Tafra
  • , Zandra Cheng
  • , Joseph Uddo
  • , Mary B. Lobrano
  • , William Stein
  • , Wendie A. Berg
  • , Edward Levine
  • , Irving N. Weinberg
  • , Deepa Narayanan
  • , Eric Ross
  • , David Beylin
  • , Stephen Yarnall
  • , Rochelle Keen
  • , Kristen Sawyer
  • , Jack Van Geffen
  • , Rita L. Freimanis
  • , Edward Staab
  • , Lee P. Adler
  • , Judy Lovelace
  • , Perry Shen
  • John Stewart, Sergei Dolinsky
  • Anne Arundel Health Systems
  • East Jefferson General Hospital
  • Johns Hopkins University
  • Wake Forest University
  • Naviscan PET Systems, Inc.
  • Fox Chase Cancer Center

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Abstract

Background: High-resolution positron-emission mammography (PEM) is a new device, which allows the imaging of breast tissue. A prospective study was performed to assess the accuracy of PEM in newly diagnosed breast cancer patients. Methods: In a prospective multicenter study, 44 women with confirmed breast cancers were imaged with a high-resolution PEM scanner (Naviscan PET Systems, Rockville, MD) with 18F-fluorodeoxyglucose. The images were blindly evaluated and were compared with final pathology. Results: The majority of the index lesions were seen on PEM (89%, 39/44). PEM detected 4 of 5 incidental breast cancers, 3 of which were not seen by any other imaging modalities. Of 19 patients undergoing breast-conserving surgery, PEM correctly predicted 6 of 8 (75%) patients with positive margins and 100% (11/11) with negative margins. Conclusion: The current PEM device shows promise in detecting breast malignancies and may assist in the planning of adequate partial mastectomy procedures to better ensure negative margins.

Original languageEnglish
Pages (from-to)628-632
Number of pages5
JournalAmerican Journal of Surgery
Volume190
Issue number4
DOIs
StatePublished - Oct 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms/diagnostic imaging
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Mammography/methods
  • Middle Aged
  • Pilot Projects
  • Positron-Emission Tomography/methods
  • Predictive Value of Tests
  • Prospective Studies
  • Radiopharmaceuticals
  • Single-Blind Method

Fingerprint

Dive into the research topics of 'Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer'. Together they form a unique fingerprint.

Cite this